Financials COSMOS Pharmaceutical Corporation

Equities

3349

JP3298400007

Drug Retailers

Market Closed - Japan Exchange 02:00:00 2024-06-28 EDT 5-day change 1st Jan Change
12,975 JPY -0.57% Intraday chart for COSMOS Pharmaceutical Corporation +1.61% -20.33%

Valuation

Fiscal Period: May 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 339,761 612,599 603,094 483,107 525,081 514,184 - -
Enterprise Value (EV) 1 329,286 567,537 553,560 450,132 497,354 484,429 482,365 476,221
P/E ratio 17.7 x 28.6 x 22.2 x 20.9 x 22.1 x 20.5 x 19.4 x 18 x
Yield 0.58% 0.36% 0.46% 0.66% 0.75% 0.9% 1% 1.08%
Capitalization / Revenue 0.56 x 0.9 x 0.83 x 0.64 x 0.63 x 0.53 x 0.49 x 0.45 x
EV / Revenue 0.54 x 0.83 x 0.76 x 0.6 x 0.6 x 0.5 x 0.46 x 0.42 x
EV / EBITDA 8.73 x 13.3 x 11.8 x 10 x 10.5 x 9.32 x 8.63 x 8 x
EV / FCF 75.9 x 14.7 x 65.2 x -39.1 x 93.5 x 76.5 x 52.5 x 54.9 x
FCF Yield 1.32% 6.78% 1.53% -2.56% 1.07% 1.31% 1.9% 1.82%
Price to Book 2.69 x 4.21 x 3.54 x 2.54 x 2.49 x 2.22 x 2.03 x 1.86 x
Nbr of stocks (in thousands) 39,599 39,599 39,599 39,599 39,599 39,629 - -
Reference price 2 8,580 15,470 15,230 12,200 13,260 12,975 12,975 12,975
Announcement Date 19-07-12 20-07-10 21-07-12 22-07-11 23-07-10 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: May 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 611,137 684,403 726,424 755,414 827,697 965,114 1,051,899 1,137,116
EBITDA 1 37,733 42,656 46,932 44,906 47,496 51,967 55,875 59,536
EBIT 1 24,775 29,094 33,147 29,796 30,128 32,370 34,566 36,935
Operating Margin 4.05% 4.25% 4.56% 3.94% 3.64% 3.35% 3.29% 3.25%
Earnings before Tax (EBT) 1 27,139 30,402 38,596 33,048 32,773 35,007 37,335 39,986
Net income 1 19,185 21,435 27,156 23,155 23,797 25,043 26,550 28,547
Net margin 3.14% 3.13% 3.74% 3.07% 2.88% 2.59% 2.52% 2.51%
EPS 2 484.5 541.3 685.8 584.8 601.0 632.2 670.3 720.6
Free Cash Flow 1 4,337 38,505 8,494 -11,523 5,321 6,329 9,182 8,671
FCF margin 0.71% 5.63% 1.17% -1.53% 0.64% 0.66% 0.87% 0.76%
FCF Conversion (EBITDA) 11.49% 90.27% 18.1% - 11.2% 12.18% 16.43% 14.56%
FCF Conversion (Net income) 22.61% 179.64% 31.28% - 22.36% 25.27% 34.58% 30.38%
Dividend per Share 2 50.00 55.00 70.00 80.00 100.0 116.8 129.5 140.3
Announcement Date 19-07-12 20-07-10 21-07-12 22-07-11 23-07-10 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: May 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 325,269 364,175 181,729 371,138 187,747 196,529 206,122 197,894 404,016 202,286 221,395 241,653 234,777 476,430 238,881 251,307 268,050 257,562 261,694 275,844
EBITDA - - 10,066 - - - - - - - - - - - - - - - - -
EBIT 1 11,965 18,292 6,423 14,979 6,918 7,899 8,900 6,485 15,385 6,782 7,961 8,990 6,846 15,836 7,902 8,374 9,746 7,522 8,635 9,001
Operating Margin 3.68% 5.02% 3.53% 4.04% 3.68% 4.02% 4.32% 3.28% 3.81% 3.35% 3.6% 3.72% 2.92% 3.32% 3.31% 3.33% 3.64% 2.92% 3.3% 3.26%
Earnings before Tax (EBT) 1 12,945 19,221 7,423 16,636 7,761 8,651 9,581 7,183 16,764 7,468 8,541 9,636 7,577 17,213 8,729 9,754 - - - -
Net income 1 8,771 13,072 5,002 11,245 5,210 6,700 6,481 4,818 - 4,984 7,514 6,508 5,079 11,587 5,770 7,817 7,150 5,700 6,450 7,800
Net margin 2.7% 3.59% 2.75% 3.03% 2.78% 3.41% 3.14% 2.43% - 2.46% 3.39% 2.69% 2.16% 2.43% 2.42% 3.11% 2.67% 2.21% 2.46% 2.83%
EPS 2 221.5 330.1 126.3 284.0 131.6 169.2 163.7 121.7 285.3 125.9 189.7 164.4 128.2 292.5 145.6 193.0 - - - -
Dividend per Share 2 25.00 27.50 40.00 40.00 - 40.00 - 42.50 42.50 - 57.50 - 60.00 60.00 - 65.00 - 70.00 - 70.00
Announcement Date 20-01-10 21-01-12 22-01-11 22-01-11 22-04-11 22-07-11 22-10-11 23-01-13 23-01-13 23-04-10 23-07-10 23-10-11 24-01-12 24-01-12 24-04-12 - - - - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: May 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 10,475 45,062 49,534 32,975 27,727 29,755 31,819 37,963
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 4,337 38,505 8,494 -11,523 5,321 6,329 9,182 8,671
ROE (net income / shareholders' equity) 16.3% 15.8% 17.2% 12.8% 11.9% 11.4% 11% 10.9%
ROA (Net income/ Total Assets) 10.4% 10.6% 10.8% 6.57% 8.44% 7.1% 6.92% 6.91%
Assets 1 184,233 201,651 250,683 352,186 281,952 352,883 383,892 413,305
Book Value Per Share 2 3,189 3,679 4,308 4,811 5,330 5,846 6,388 6,969
Cash Flow per Share 2 812.0 884.0 1,034 693.0 1,040 1,099 1,164 1,220
Capex 1 29,040 25,948 26,064 43,497 46,636 51,157 48,871 49,129
Capex / Sales 4.75% 3.79% 3.59% 5.76% 5.63% 5.3% 4.65% 4.32%
Announcement Date 19-07-12 20-07-10 21-07-12 22-07-11 23-07-10 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
12,975 JPY
Average target price
15,884 JPY
Spread / Average Target
+22.42%
Consensus
  1. Stock Market
  2. Equities
  3. 3349 Stock
  4. Financials COSMOS Pharmaceutical Corporation